Daily happenings?., page-239

Thx Lucretious. The swimmer plot shows the two patients that moved up into 2nd and 3rd lanes with one now on the lowest dosage of 500 m/g from having also been on the highest. All part of the analysis the trial is now undergoing. Looks as though both PTCL and CTCL are neck and neck as to which is showing the most efficacy. A good problem to have - two indications in TCL deriving such great results.



So out of the 10 evaluatable patients, 6 have lived well beyond SOC and even our duration target with 5 of them still alive as at the date of the data in July... plus we have another recruited patient on the highest dose and approaching SOC at the time. Four months on and with further recruitments, hopefully we can add more equally impressive data.